Blood clot registry aims to uncover hidden risk factors
NCT ID NCT02188056
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study followed 300 patients with venous thromboembolism (blood clots in veins) to track how often clots return or cause bleeding. Researchers hope to find new risk factors and compare newer blood thinners. The study only observes, so it cannot test treatments directly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help identify new risk factors for blood clots and improve treatment comparisons.
- What could go wrong
- This is an observational study, not a treatment trial, so it cannot prove cause and effect. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLIC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service Des Maladies Vasculaires - Hta - Nhc
Strasbourg, 67091, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your family history predict Hormone-Related blood clots?
- Pregnant women needed for blood clot study
- Can a simple walk reveal hidden clot risks?
- Blood clot patients on heart meds: safer combo found?
- Gene test could predict heart attack and stroke risk
- Blood thinner breakthrough could stop clots in rare anemia